Accuracy of patient self-report as a measure of inhaled asthma medication use

Respirology

Volumn 18, Issue 3, 2013, Pages 546-552

  Patel, Mitesh ^a,b,d   Perrin, Kyle ^a,b   Pritchard, Alison ^a   Williams, Mathew ^a   Wijesinghe, Meme ^a,b   Weatherall, Mark ^b,c   Beasley, Richard ^a,b,c  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

adherence; asthma; Bland Altman plot; electronic monitoring; self report

Indexed keywords

FLUTICASONE PROPIONATE; LONG ACTING DRUG; SALMETEROL;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; COMPARATIVE STUDY; DRUG USE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION; MAJOR CLINICAL STUDY; METERED DOSE INHALER; PATIENT COMPLIANCE; PERSONAL MONITORING; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SELF REPORT;

ADMINISTRATION, INHALATION; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG DOSAGE CALCULATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SELF REPORT;

EID: 84875649227     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12059     Document Type: Article

References (34)

1. Holgate S, Bisgaard H, Bjermer L, et al. The Brussels Declaration: the need for change in asthma management. Eur. Respir. J. 2008; 32: 1433-1442.
2. Horne R,. Compliance, adherence, and concordance. Chest 2006; 130 (1 Suppl.): 65S-72S.
3. National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. 2007. [Accessed 25 Jun 2012.] Available from URL: http://www.nhlbi.nih.gov/
4. Foster JM, Smith L, Bosnic-Anticevich SZ, et al. Identifying patient-specific beliefs and behaviours for conversations about adherence in asthma. Intern. Med. J. 2012; 42: e136-144.
5. Heaney LG, Horne R,. Non-Adherence in difficult asthma: time to take it seriously. Thorax 2012; 67: 268-270.
6. Juniper EF, O'Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 1999; 14: 902-907.
7. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J. Allergy Clin. Immunol. 2004; 113: 59-65.
8. Scottish Intercollegiate Guidelines Network/British Thoracic Society. British guideline on the management of asthma. Thorax 2008; 63 (Suppl. 4): iv1-121. Revised January 2012. [Accessed 25 Jun 2012.] Available from URL: http://www.brit-thoracic.org.uk/
9. Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994; 344: 219-224.
10. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N. Engl. J. Med. 1997; 337: 1405-1411.
11. Apter AJ, Tor M, Feldman HI,. Testing the reliability of old and new features of a new electronic monitor for metered dose inhalers. Ann. Allergy Asthma Immunol. 2001; 86: 421-424.
12. Simmons MS, Nides MA, Kleerup EC, et al. Validation of the Doser, a new device for monitoring metered-dose inhaler use. J. Allergy Clin. Immunol. 1998; 102: 409-413.
13. Bender B, Wamboldt FS, O'Connor SL, et al. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann. Allergy Asthma Immunol. 2000; 85: 416-421.
14. Berg J, Dunbar-Jacob J, Rohay J,. Compliance with inhaled medications: the relationship between diary and electronic monitor. Ann. Behav. Med. 1998; 20: 36-38.
15. Burgess SW, Sly PD, Morawska A, et al. Assessing adherence and factors associated with adherence in young children with asthma. Respirology 2008; 13: 559-563.
16. Spector SL, Kinsman R, Mawhinney H, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J. Allergy Clin. Immunol. 1986; 77 (1 Pt 1): 65-70.
17. Riekert KA, Rand CS,. Electronic monitoring of medication adherence: when is high-tech best? J. Clin. Psychol. Med. Settings 2002; 9: 25-34.
18. Perrin K, Williams M, Wijesinghe M, et al. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-Acting beta-Agonist inhaler therapy in asthma. J. Allergy Clin. Immunol. 2010; 126: 505-510.
19. Smartinhaler Tracker Product Details. Nexus 6 Limited, Auckland, New Zealand. [Accessed 25 Jun 2012.] Available from URL: http://www.smartinhaler. com/clinical/products/smartinhalertracker.aspx
20. Burgess SW, Wilson SS, Cooper DM, et al. In vitro evaluation of an asthma dosing device: the smart-inhaler. Respir. Med. 2006; 100: 841-845.
21. Chan AHY, Hamed M, Foster JM, et al. In-vitro validation testing of electronic adherence monitoring devices Australasian Pharmaceutical Science Association Annual Conference 2009: Program and Abstracts 2009; Hobart, Tasmania, Australia.
22. Bland JM, Altman DG,. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
23. Bland JM, Altman DG,. Measuring agreement in method comparison studies. Stat. Methods Med. Res. 1999; 8: 135-160.
24. Myles PS, Cui J,. Using the Bland-Altman method to measure agreement with repeated measures. Br. J. Anaesth. 2007; 99: 309-311.
25. Beasley R, Martinez FD, Hackshaw A, et al. Safety of long-Acting β-Agonists: urgent need to clear the air remains. Eur. Respir. J. 2009; 33: 3-5.
26. Diette GB, Wu AW, Skinner EA, et al. Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled beta-Agonists and underuse of inhaled corticosteroids. Arch. Intern. Med. 1999; 159: 2697-2704.
27. Patel M, Perrin K, Beasley R,. Beta agonist use during asthma exacerbations: how much is too much? N. Z. Med. J. 2011; 124: 77-80.
28. Windom HH, Burgess CD, Crane J, et al. The self-Administration of inhaled beta agonist drugs during severe asthma. N. Z. Med. J. 1990; 103: 205-207.
29. Simmons MS, Nides MA, Rand CS, et al. Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest 2000; 118: 290-295.
30. Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am. Rev. Respir. Dis. 1992; 146: 1559-1564.
31. Simmons MS, Nides MA, Rand CS, et al. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 1996; 109: 963-968.
32. Haughney J, Price D, Kaplan A, et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir. Med. 2008; 102: 1681-1693.
33. Horne R, Price D, Cleland J, et al. Can asthma control be improved by understanding the patient's perspective? BMC Pulm. Med. 2007; 7: 8.
34. Rand CS, Wright RJ, Cabana MD, et al. Mediators of asthma outcomes. J. Allergy Clin. Immunol. 2012; 129 (3 Suppl.): S136-141.